Biolog Device Statistics

Total Valuation

Biolog Device has a market cap or net worth of KRW 27.74 billion. The enterprise value is 30.71 billion.

Market Cap	27.74B
Enterprise Value	30.71B

Important Dates

The next estimated earnings date is Thursday, March 20, 2025.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Biolog Device has 65.90 million shares outstanding. The number of shares has increased by 41.07% in one year.

Current Share Class	n/a
Shares Outstanding	65.90M
Shares Change (YoY)	+41.07%
Shares Change (QoQ)	+2.39%
Owned by Insiders (%)	0.91%
Owned by Institutions (%)	n/a
Float	37.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.17
PB Ratio	0.50
P/TBV Ratio	0.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.51, with an EV/FCF ratio of -6.54.

EV / Earnings	-2.04
EV / Sales	0.21
EV / EBITDA	4.51
EV / EBIT	n/a
EV / FCF	-6.54

Financial Position

The company has a current ratio of 1.18, with a Debt / Equity ratio of 0.25.

Current Ratio	1.18
Quick Ratio	0.96
Debt / Equity	0.25
Debt / EBITDA	1.81
Debt / FCF	-2.86
Interest Coverage	-7.09

Financial Efficiency

Return on equity (ROE) is -21.47% and return on invested capital (ROIC) is -6.11%.

Return on Equity (ROE)	-21.47%
Return on Assets (ROA)	-4.53%
Return on Capital (ROIC)	-6.11%
Revenue Per Employee	5.29B
Profits Per Employee	-536.64M
Employee Count	28
Asset Turnover	1.69
Inventory Turnover	20.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -48.88% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-48.88%
50-Day Moving Average	414.92
200-Day Moving Average	543.08
Relative Strength Index (RSI)	60.01
Average Volume (20 Days)	299,227

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biolog Device had revenue of KRW 148.00 billion and -15.03 billion in losses. Loss per share was -244.94.

Revenue	148.00B
Gross Profit	4.04B
Operating Income	-6.34B
Pretax Income	-9.86B
Net Income	-15.03B
EBITDA	7.41B
EBIT	-6.34B
Loss Per Share	-244.94

Full Income Statement

Balance Sheet

The company has 7.31 billion in cash and 13.42 billion in debt, giving a net cash position of -6.10 billion or -92.62 per share.

Cash & Cash Equivalents	7.31B
Total Debt	13.42B
Net Cash	-6.10B
Net Cash Per Share	-92.62
Equity (Book Value)	52.69B
Book Value Per Share	847.15
Working Capital	6.56B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -149.38 million and capital expenditures -4.54 billion, giving a free cash flow of -4.69 billion.

Operating Cash Flow	-149.38M
Capital Expenditures	-4.54B
Free Cash Flow	-4.69B
FCF Per Share	-71.21

Full Cash Flow Statement

Margins

Gross margin is 2.73%, with operating and profit margins of -4.29% and -10.15%.

Gross Margin	2.73%
Operating Margin	-4.29%
Pretax Margin	-6.66%
Profit Margin	-10.15%
EBITDA Margin	5.01%
EBIT Margin	-4.29%
FCF Margin	n/a

Dividends & Yields

Biolog Device does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-41.07%
Shareholder Yield	-41.07%
Earnings Yield	-58.18%
FCF Yield	-16.92%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Biolog Device has an Altman Z-Score of 2.03. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.03
Piotroski F-Score	n/a